Intravitreal anti-vascular endothelial growth factor monotherapy for large submacular hemorrhage secondary to neovascular age-related macular degeneration

PURPOSE: To evaluate the efficacy of anti-vascular endothelial growth factor (VEGF) monotherapy for large submacular hemorrhage (SMH) secondary to neovascular age-related macular degeneration (nAMD). METHODS: A total of 49 treatment-naive patients (49 eyes) with large SMH (more than five disc areas...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eye (Lond)
Auteurs principaux: Kim, H S, Cho, H J, Yoo, S G, Kim, J H, Han, J I, Lee, T G, Kim, J W
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2015
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4565949/
https://ncbi.nlm.nih.gov/pubmed/26272443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.131
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires